Esbriet

Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Roche
generics
Esbriet
IPF
Roche evaluates options for its lung disease drug
Reuters
Mon, 02/26/24 - 05:12 pm
Roche
Esbriet
lung cancer
Late-stage pipeline for idiopathic pulmonary fibrosis is small but growing
Clinical Trials Arena
Mon, 06/19/23 - 11:39 am
IPF
Roche
Esbriet
Pirespa
Boehringer Ingelheim
Ofev
Novartis' Sandoz strikes at Roche with first US generic of blockbuster Esbriet
Fierce Pharma
Fri, 05/13/22 - 10:46 am
Novartis
Sandoz
generics
Roche
Esbriet
idiopathic pulmonary fibrosis
Roche comes up short in its attempt to hold off generic competition to Esbriet
Endpoints
Thu, 03/24/22 - 08:38 pm
Roche
Esbriet
IPF
generics
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
Endpoints
Thu, 01/21/21 - 10:36 am
Roche
Esbriet
IPF
FDA
priority review
Genentech's Esbriet Granted Breakthrough Therapy Designation for uILD
BioSpace
Wed, 03/4/20 - 10:47 am
Genentech
Esbriet
uILD
breakthrough therapy
FDA
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Tue, 02/5/19 - 11:19 pm
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics
Boehringer revs up Ofev sales force, support services to rival Roche's Esbriet in IPF
Fierce Pharma Marketing
Thu, 10/23/14 - 08:41 am
Boehringer Ingelheim
drug reps
Ofev
Roche
Esbriet
IPF
Roche, Boehringer Drugs Wins Approval for Lung Disease
Bloomberg
Wed, 10/15/14 - 04:49 pm
Roche
Boehringer Ingelheim
FDA
IPF
idiopathic pulmonary fibros
Esbriet
Ofev
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Yahoo/Benzinga
Thu, 07/3/14 - 12:07 pm
FDA
drug approvals
Acadia
Alexion
InterMune
Merrimack Pharmaceuticals
Soliris
pimavanserin
MM-398
Esbriet
The Path to FDA Approval Could Launch Seven Biotech Stocks Much Higher
24/7 Wall St
Wed, 07/2/14 - 11:49 am
Alexion
InterMune
FDA
Acadia
Kythera
Intercept Pharmaceuticals
Merrimack Pharmaceuticals
Relypsa
MM-398
patiromer
Esbriet
ATX-101
Soliris
Flint
pimavanserin
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
InterMune
Esbriet
Actelion
Gilead Sciences
Better Buyout Candidate: Chelsea Therapeutics International Ltd. vs. InterMune Inc.
Motley Fool
Mon, 03/17/14 - 05:05 pm
Chelsea Therapeutics
Northera
Esbriet
idiopathic pulmonary fibrosis
InterMune
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Mon, 03/10/14 - 05:05 pm
M&A
InterMune
Sanofi
Esbriet
Boehringer Ingelheim
Novartis
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
InterMune: Esbriet And Ascend Will Drive Growth
Seeking Alpha
Sat, 12/21/13 - 11:32 am
InterMune
Esbriet
idiopathic pulmonary fibrosis
InterMune says it is selling 6.5M shares to fund marketing and studies of lung disease drug
Yahoo/AP
Wed, 11/6/13 - 11:21 am
InterMune
stock offering
Esbriet
InterMune Successfully Entering Huge Niche Market Unchallenged
Seeking Alpha
Sun, 07/28/13 - 11:18 am
InterMune
Esbriet
idiopathic pulmonary fibrosis
SEC Sues Ex-InterMune Finance Chief Alleging Esbriet Tips
Bloomberg
Fri, 06/7/13 - 10:21 am
SEC
InterMune
Esbriet

Pages